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Unfolded stress response (UPR) is a conserved cellular pathway involved in protein
quality control to maintain homeostasis under different conditions and disease states
characterized by cell stress. Although three general schemes of and genes induced by
UPR are rather well-established, open questions remain including the precise role of UPR
in human diseases and the interactions between different sensor systems during cell
stress signaling. Particularly, the issue how the normally adaptive and pro-survival UPR
pathway turns into a deleterious process causing sustained endoplasmic reticulum (ER)
stress and cell death requires more studies. UPR is also named a friend with multiple
personalities that we need to understand better to fully recognize its role in normal
physiology and in disease pathology. UPR interacts with other organelles including
mitochondria, and with cell stress signals and degradation pathways such as autophagy
and the ubiquitin proteasome system. Here we review current concepts andmechanisms
of UPR as studied in different cells and model systems and highlight the relevance of UPR
and related stress signals in various human diseases.
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Progress made in recent years has greatly increased our understanding about mechanisms
of protein homeostasis at the organelle level such as the endoplasmic reticulum (ER) and
mitochondria observed during cell stress and in disease. In the ER, the unfolded protein response
(UPR) exerts an adaptive function in protein quality control to ensure the proper synthesis,
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secretion, and correct folding of proteins (Walter and Ron,
2011), whilst mitochondria have their own quality control system
known as themitochondrial unfolded protein response, UPR(mt)
(Haynes and Ron, 2010). UPR is activated following cell stress
in several human disorders, as illustrated in Figure 1, including
neurodegenerative diseases, diabetes and metabolic disorders,
atherosclerosis, cancer, as well as renal and lung diseases (Wang
and Kaufman, 2012; Hipp et al., 2014). UPR can have contrasting
effects in these being either cell protective or cell destructive
depending on the strength or duration of the primary insult
(Tabas and Ron, 2011; Sano and Reed, 2013). Chronic, sustained
UPR usually causes cell death and is described as ER stress but
a continuously active UPR is a characteristic of many secretory
cells (Moore and Hollien, 2012). UPR signaling plays also a
role in development and in normal physiological processes and
can influence higher brain functions and neuronal plasticity.
In the following, we discuss current concepts and molecular
mechanisms underlying UPR and UPR(mt) with a focus on
human diseases and the possibilities for novel treatments in
protein misfolding diseases.
UPR—A FRIEND WITH MULTIPLE
PERSONALITIES
Sensor Proteins for UPR in the ER
During UPR, transmembrane proteins in the ER act as
sensors to detect disturbances in protein handling (proteostasis)
caused by misfolded/mutant proteins, or by alterations in
signaling networks or in the ionic balance such as calcium
in the cell. Three major signaling pathways characterize the
UPR; the inositol-requiring enzyme 1α (IRE1α), the protein
kinase RNA-like endoplasmic reticulum kinase (PERK) and
the activating transcription factor 6 (ATF6; Figure 1). These
proteins have distinct but overlapping functions in UPR and
are structurally composed of specific subdomains. IRE1α has
a cytosolic kinase domain that and phosphorylated IRE1α
associates withmolecules such the c-JunN-aminoterminal kinase
(JNK) involved in cell death regulation (Hetz et al., 2011; Walter
and Ron, 2011). IRE1α has also an endoribonuclease activity
that cleaves out a 26 bp intron from the pre-mRNA of X-box
binding protein-1 (XBP-1) producing an active transcription
factor that upregulates expression of genes involved in protein
folding (like the ER chaperon GRP78/BiP), in ER-associated
protein degradation (ERAD) pathway, and in lipid synthesis.
The increased protein folding capacity and degradation of
misfolded proteins induced by XBP-1 contribute to restored
protein homeostasis and increased cell survival following stress.
XBP-1 has also other functions in the cell that are now being
explored inmore details (see below). In addition, activated IRE1α
can cleave certain RNA molecules in a process called IRE1α-
dependent decay of mRNAs (RIDD) though the functional
significance of this is not fully understood.
Recent studies on the crystal structure of yeast IRE1α have
depicted a likely mechanism by which unfolded proteins and
peptides can directly bind to and interact with the luminal
domain of the molecule. IRE1α then self-associates to produce
oligomers that are observed as large foci in the ER using
microscopy (Gardner and Walter, 2011). The binding of
unfolded peptides to IRE1 has so far been shown mainly using
the yeast protein but the mammalian IRE1 shows a rather
homologous structure, suggesting similar mode of regulation.
This mode of IRE1α regulation by unfolded peptides is at
variance with previous thoughts indicating that the binding of
BiP is crucial in keeping IRE1α signaling at bay in the ER.
However, it is likely that BiP plays a role in fine-tuning of the UPR
and overexpression of BiP in different cells reduces ER stress and
increases cell survival.
Protein kinase RNA-like endoplasmic reticulum kinase
(PERK) is a protein kinase that phosphorylates downstream
targets such as the eukaryotic translation initiation factor-2α
(eIF2α). This leads to a reduction in general protein synthesis
with a decrease in the load of misfolded/mutant proteins in
the ER. However, the translational block is not complete and a
subset of mRNAs including that encoding the transcription factor
ATF4 are still being translated leading to increased expression
of among others the growth arrest and DNA damage-inducible
34 (GADD34), the transcription factor C/EBP homologous
protein (CHOP) as well as pro-apoptotic BCL-2 family proteins.
GADD34, also called PPP1R15A, is a phosphatase for p-IF2α
with the ability to restore protein synthesis. The degree of eIF2α
phosphorylation is dynamically regulated in the cell and this can
be interfered with using specific compounds to control ER stress
in various diseases (see below).
The timing of induction of the different UPR pathways and
their mutual interactions are important issues and ultimately
determine the cell response to stress. Thus, an early and transient
increase in IRE1α mediates cell protection, whilst an early-
onset increase in PERK-ATF4 causes cell degeneration (Walter
et al., 2015). An example of contrasting effects of UPR-controlled
signals is also shown by the death receptor 5 (DR5) that is
increased by the PERK-CHOP pathway but whose mRNA is
cleaved by the endonuclease of IRE1α (Lu et al., 2014). DR5
is important for tumor cell killing and UPR signaling may
accordingly influence cancer growth.
In contrast to IRE1α and PERK, ATF6 is first being
transported from the ER to the Golgi compartment where
it then becomes activated by intramembranous proteolysis
mediated by site-1 and site-2 proteases causing the release of the
transcriptionally active form of ATF6 (Walter and Ron, 2011).
This mode of regulation resembles that of the sterol regulatory
element-binding proteins (SREBPs) that are transcription factors
for genes involved in lipid and cholesterol metabolism. However,
like IRE1α, ATF6 upregulates gene expression of ER chaperons,
ERAD components, as well as of XBP-1 (Tabas and Ron, 2011;
Sano and Reed, 2013). There are two closely related ATF6
genes, ATF6α and ATF6β and double gene deleted mice are
embryonically lethal. ATF6 plays a role in development as studied
in themedaka fish (Oryzias latipes). ER stress is part of the normal
development of the brain and of notochord in medaka, caused by
the preponderate synthesis of extracellular matrix (EM) proteins
required for organogenesis (Ishikawa et al., 2011). The lack
of ATP6 decreased the levels of BiP and other chaperones
reducing the folding and transport of EM proteins such as
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FIGURE 1 | List of human disorders associated with activation of the unfolded protein response and ER stress.
pro-collagen that interferes with early development (Ishikawa
et al., 2013). Several proteins are involved in pro-collagen
trafficking including the large protein particle (TRAPP) multi-
subunit protein complex, and involves large vesicles different
from ordinary coat protein complex II (COPII) ones, mediating
ER-Golgi transport (Venditti et al., 2012).
Other ER Proteins Involved in Cell
Signaling and Stress
Members of the astrocyte specifically induced substance (OASIS)
protein family are transcription factors that are latent in the ER
and activated in a process resembling that of ATF6 (Kondo et al.,
2012). These proteins are expressed in a time and cell-specific
manner important for their functions. The box B-binding factor-
2 human homolog on chromosome 7 (BBF2H7) is present in
developing chondrocytes and is activated by ER stress (Izumi
et al., 2012). In the nucleus BBF2H7 increases gene expression
of proteins involved in the secretion of EM proteins such as
collagen. It is considered that BBF2H and ATF6 may act in
parallel to enhance cell survival and ensure proper synthesis of
EM components during development and after injury.
The nuclear factor erythroid-derived 2-related factor
1 (NRF1) is a transcription factor residing latent in the
ER membrane involved in the regulation of expression of
antioxidants and ERAD components. NRF1 shares many of its
activities with the related factor NRF2, but NRF1 can specifically
increase proteins associated with the proteasomes to promote
protein degradation. NRF1 can be activated by different factors
and events including ER stress (Zhang and Xiang, 2016).
Recent studies showed that NRF1 is induced downstream of
the target of rapamycin complex-1 (mTORC1) protein that
is usually associated with the stimulation of protein synthesis
and anabolic processes in the cell. These results indicate that
mTORC1 signaling through NRF1 also increases proteasomes
Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 May 2017 | Volume 5 | Article 48
Lindholm et al. UPR and ER Stress in Human Diseases
enhancing protein turnover, which is equally important for
protein homeostasis. The physiological relevance of NRF1 and
NRF2 in different cells and human diseases warrants further
studies.
Wolframin (WFS1) is a transmembrane ER resident protein
encoded by theWFS1 gene that in amutant form causesWolfram
syndrome 1 (WS1), an autosomal recessive degenerative disease
characterized by insulin-dependent diabetes mellitus, optic
atrophy, deafness and various neurological symptoms (Hofmann
et al., 2003). WFS1 is a component of the UPR and participate
in the IRE1 and PERK signaling to maintain ER homeostasis
(Fonseca et al., 2005). The promoter region of WFS1 gene has
ER stress response element (ERSE) like sequence and WFS1
expression is increased during ER stress by XBP1 and ATF6
(Kakiuchi et al., 2006; Odisho et al., 2015) WFS1 stabilizes the
yeast E3 ubiquitin ligase HRD1 (SYVN1 in humans) involved
in ERAD and enhances the proteasome-mediated degradation of
ATF6α thereby reducing ER stress signaling (Fonseca et al., 2010).
Lack of functional WFS1 protein makes cells more vulnerable to
different environmental insults (Kõks et al., 2013), and pancreatic
β-cells degenerate in WFS1 gene deleted mice subsequent to
ER-stress (Ishihara et al., 2004).
UPR IN CONTROL OF PROTEIN
SECRETION
Protein quality control is tightly linked to protein sorting and
secretion. Protein export from ER to the Golgi compartment
is a highly dynamic process governed by various signals
and regulatory molecules (Gomez-Navarro and Miller, 2016).
Deregulated trafficking of cell surface proteins occurs in human
diseases such as cystic fibrosis (CF) caused by mutations in
CF transmembrane conductance regulator gene, CFTR (Schmidt
et al., 2016). One major disease-causing mutation in CFTR is
called F508del-CFTR and it is found in about two-third of
aﬄicted patients with retention of the misfolded protein in the
ER and degraded via the ERAD pathway (Schmidt et al., 2016).
Current studies attempt to interfere with the transport of mutant
CFR to increase its expression at the cell surface to reverse
pathology (Adnan et al., 2016). This is important and may in the
future open up new possibilities for treatment of CF and other
diseases with protein transport defects. However, a lesson learned
from studies of the yeast ATP-binding cassette transporter Yor1p,
a homolog of mammalian CFTR, is that the interconnections
between protein retention and ERAD of mutant proteins are
complex and competing signals control protein trafficking in the
ER (Pagant et al., 2007).
Plasma cells are like the insulin producing β-cells are
specialized secretory cells with a high biosynthetic capacity. UPR
and active IRE1α/XBP-1 signaling is crucial at an early stage
during differentiation of the plasma cells from B-lymphocytes.
UPR plays an important role during the immune response when
large quantities of antibodies are made and secreted by these cells
(Cenci et al., 2011). It has been shown that after syntheses are the
immunoglobulin heavy chains linked together as larger oligomers
in the ER via the C-terminal cysteine. These complexes are
subsequently disassembled following UPR to allow for secretion
of the immunoglobulin (van Anken et al., 2014). The fine-tuning
and function of specific chaperons in this process are important
study objectives in the future (Sannino et al., 2014).
UPR plays also a role in secretion of aggregate-prone proteins
to the extracellular space. Such proteins are often misfolded and
accumulate in tissues in form of soluble aggregates or fibrils
as shown in many human amyloidosis diseases (Chen et al.,
2015). Activation of UPR can increase the levels of secreted
chaperons, as exemplified by the protein ERdj3 (also called B11),
and thus influence protein homeostasis also at the cell surface
and coordinate it with that inside the cell (Genereux et al.,
2015). As shown for mutant transthyretin (TTR) protein, ATF6
signaling is able to counteract amyloid formation and cytotoxicity
by reducing secretion of misfolded TTR (Chen J. J. et al.,
2014). Recently small molecular compounds were developed
that mimic the actions of ATF6 in decreasing amyloidogenic
protein accumulation in a process named ER reprogramming
by the authors (Plate et al., 2016a). The novel compounds affect
secretion of misfolded proteins and are useful tools to study
ER stress but may also in the long-run help to design better
therapeutics for amyloidosis diseases in human (Eisele et al.,
2015).
MITOCHONDRIAL UPR
Like the ER, mitochondria respond to cell stress and have
their own protein quality control system known as UPR(mt)
(Haynes and Ron, 2010; Jovaisaite et al., 2014). As studied
mainly in the worm Caenorhabditis elegans the UPR(mt) initiates
a cascade of reactions to promote nuclear transcription of
mitochondrial chaperones and protective factors for organelle
repair and homeostasis. Recently it was shown using myoblasts
that the catalytic ATP-dependent Clp protease ATP-binding
subunit (ClpX) in the protease complex, ClpXP, degrades
misfolded/unfolded or oxidized proteins in the mitochondria
during mammalian mitochondrial stress (Al-Furoukh et al.,
2015). A novel substrate of the mammalian ClpXP is the matrix
protein, nitric oxide-associated protein 1 that is a GTPase
involved in the regulation of mitochondrial protein synthesis,
cell death and in oxidative respiration (Heidler et al., 2011;
Al-Furoukh et al., 2014). Increased oxidative stress is part
of human degenerative diseases and involved mitochondria
production of reactive oxygen species (ROS). Recent studies
showed that themitochondria inner membrane protease, YME1L
is particularly sensitive to ROS resulting in reduced capacity
for proteolysis of key mitochondrial proteins during cell stress
(Rainbolt et al., 2015). YME1L belongs to the family of ATP-
dependent AAA+ quality control proteases including also the
AFG3L2 and paraplegin proteins. Mutations in or loss of
these protein lead to impaired mitochondria functions and
can cause human diseases exemplified by spinocerebellar ataxia
type 28 and hereditary spastic paraplegia type 7 (Casari et al.,
1998; Di Bella et al., 2010). Alterations in mitochondria are
also linked to pathogenesis of different diseases (Nunnari
and Suomalainen, 2012). As shown in yeast a decreased
mitochondrial protease activity may increase the formation of
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protein aggregation further worsening cell stress (Erjavec et al.,
2013).
In C. elegans, the activating transcription factor associated
with stress-1 (ATFS-1) is a key factor in the control of UPR(mt)
mediating a crosstalk between mitochondria and nucleus. The
protein is normally imported into the mitochondria but during
cell stress the mitochondrial import machinery is impaired
increasing ATFS-1 in the nucleus inducing expression of
UPR(mt)-associated genes (Nargund et al., 2012). ATFS-1 is also
involved in the innate immunity response and protection against
pathogens (Pellegrino et al., 2014). Mutations and deletions
in mitochondrial DNA (mtDNA) are associated with UPR(mt)
and cellular aging although the situation is complex. Thus, it
was shown that UPR(mt) is constitutively activated in a the
heteroplasmic C. elegans strain that helps to maintain the high
amount of mtDNA deletions present (Lin et al., 2016). It remains
to be studied whether similar mechanisms prevail in mammalian
cells for example during aging. Recently, it was found that the
activating transcription factor (ATF5) plays a similar role in
mitochondrial stress in mammalian cells as ATFS-1 does in C.
elegans (Fiorese et al., 2016). The functional relationship of the
ATF5-mediated pathway to those of selective mitophagy and
to fission/fusion events governing mitochondrial dynamics in
mammalian cells and in diseases like Parkinson’s disease (PD)
requires further studies.
UPR IN NEURODEGENERATIVE
DISORDERS
Neurodegenerative disorders such as Alzheimer’s disease (AD),
PD, amyotrophic lateral sclerosis (ALS), and Huntington’s
disease (HD) have all distinct clinical signs band are characterized
by the accumulation of misfolded and aggregated proteins
(Lindholm et al., 2006; Hetz and Mollereau, 2014). Chronic
ER stress contributes to the disease pathology as shown by
manipulation of UPR signals using mouse genetics or by specific
compounds and drugs. Results indicate that the role of UPR in
the different disorders is complex and depends on the timing,
strength and nature of the specific pathological insult underlying
the disease.
UPR in ALS, PD, and HD
UPR has been shown to play a dual role in neurodegeneration
as the lack of XBP1 increased survival in a ALS mouse model
(Hetz et al., 2009). This was unexpected in view of the protective
functions associated with IRE1α /XBP1 signaling. Further data
showed that XBP1 deficiency increased autophagy through
the forkhead box 01 (FOXO1) transcription factor improving
the degradation of mutant SOD1 protein (Hetz et al., 2009).
In dopaminergic neurons degenerating in PD, XBP1 deletion
produce different outcomes depending on the age of the animals
and reflecting compensatory changes in UPR-regulated factors.
Thus, the lack of XBP1 during development induced a mild ER
stress with protection of dopamine neurons against neurotoxicity
of 6-hydroxydopamine, whilst silencing XBP1 in adulthood led
to chronic ER stress and the loss of dopamine neurons (Valdés
et al., 2014). In transgenic mice expressing mutant alfasunyclein
as a model for PD, the administration of salubrinal inhibiting
the PPP1R15A/GADD34 phosphatase inducing phospho-eIF2α
levels was found to be neuroprotective suggesting an involvement
of the PERK pathway in dopamine neuron degeneration (Colla
et al., 2012).
In an acute neuronal injury, local delivery of XBP1 was
beneficial increasing cell survival and the locomotion of animals
after a spinal cord lesion (Valenzuela et al., 2012). These findings
indicate that manipulation of IRE1α /XBP1 signaling is a possible
target for development of therapeutics in different neurological
diseases. XBP1 can influence also other functions in neurons than
ER stress including learning and memory formation (Martínez
et al., 2016). The effect of XBP1 was associated with changes
in the expression of brain-derived neurotrophic factor (BDNF)
that influences neuronal plasticity and long-term potentiation.
Learning and memory are also regulated by the phosphorylation
state of eIF2α influenced by PERK as well as other kinases in
the neurons (Placzek et al., 2016). The role of UPR in memory-
related processed in brain remain an interesting avenue to
explore.
In ALS, spinal cord motor neurons and corticospinal motor
neurons (CSMNs) in brain cortex undergo cell degeneration by
mechanisms only partly understood. Transgenic mice expressing
fluorescent labeled ubiquitin C-terminal hydrolase-L1 (UCHL1)
in the CSMNs showed that these neurons are particularly
sensitive to ER stress and to the lack of UCHL1 the ALS-
associated gene, Alsin (Jara et al., 2015; Gautam et al., 2016).
Cell stress and autophagy contributed to cell degeneration in the
CSMNs pointing to novel targets for intervention. Recent data
have shown that ALS and frontotemporal dementia share a major
genetic risk factor related to the presence of a hexanucleotide
repeat expansion in the gene, C9orf72 (Renton et al., 2011).
Studies of CSMNs may give novels insights into the molecular
mechanisms underlying the neuronal dysfunctions in these
diseases.
One target for intervention in ALS may be
PPP1R15A/GADD34 increasing the levels of phospho-eIF2α.
Along this line it was shown that the compound guanabenz was
able to prolong eIF2α phosphorylation and improve proteostasis
in stressed human cells (Tsaytler et al., 2011). However,
guanabenz as an adrenergic agonist causes also hypotension
and therefore cannot be used in humans. Subsequent screening
led to the identification of another molecule, Sephin1 (selective
inhibitor of a holophosphatase) that can inhibit the stress-
induced phosphatase pathway and restore protein homeostasis
(Das et al., 2015). In vivo sephin1 was neuroprotective in the
mutant SOD1-ALS mouse model, and improved behavior
with no obvious adverse effects (Das et al., 2015). Sephin1 also
prevented demyelination in Charcot-Marie-Tooth disease model
caused by mutant myelin protein zero. Future studies will show
whether sephin1 or similar compounds may potentially be useful
for treatment of ALS and other protein misfolding disorders in
humans.
Studies in models of HD have shown that the lack of
XBP1 is neuroprotective by reducing the aggregation of mutant
Huntingtin protein (Htt) and increasing cell survival (Vidal
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et al., 2012). Like in ALS, XBP1 deficiency increased autophagy
and upregulated FOXO1 expression in HD (Vidal et al., 2012).
As shown recently, the ubiquitin-specific protease 14 (Usp14)
plays a role in degradation of mutant Htt by binding IRE1α
and by regulating the proteasome activity, adding a further
degree of complexity to HD pathophysiology (Hyrskyluoto
et al., 2014). The aggregation of mutant Htt may takes place
in different neuronal compartments, such as in the nucleus
and the cytosol. Recently it was shown that Htt-aggregates
are also present at the nuclear membrane interfering with
the normal nucleocytoplasmic transport of proteins and RNA
(Woerner et al., 2016). Interestingly, expression of TAR DNA
binding protein-43 (TDP-43) that is linked to pathophysiology
of ALS also affected this transport (Woerner et al., 2016). The
significance of nucleocytoplasmic alterations in HD and in other
protein misfolding diseases remains to be studied further.
UPR in AD and Prion Diseases
AD is associated with accumulation of extracellular plaques
consisting of amyloid-β (Aβ) peptides and with intracellular
neurofibrillary tangles of hyperphosphorylated tau. The
mechanisms for cell toxicity in AD are complex and related
to changes in synaptic transmission, an altered calcium
homeostasis, increased ER stress and a chronic state of
neuroinflammation (Mattsson et al., 2016). Studies made in
cell culture and in animal models of AD have shown that the
IRE1/XBP1 branch of UPR influences amyloid-β toxicity and is
either protective as in Drosophila or deleterious as in C. elegans
(Cornejo and Hetz, 2013). Moreover, activation of JNK3 by UPR
was found to increase production of amyloid-β that aggravated
ER stress (Yoon et al., 2012). Inhibition of PERK reducing
p-eIF2α levels reversed memory impairments in an AD mouse
model (Ma et al., 2013). Together these studies indicate the
involvement of specific ER signaling in AD that affects specific
neurons and neuronal circuits in various brain regions in a
time-dependent manner.
In AD, great efforts have been devoted to study the occurrence
and toxicity of different forms of Aβ peptides (Tipping
et al., 2015). Amyloid plaques contain also non-protein factors
including glycosaminoglycan (GAG) polysaccharides that can
increase the rate of Aβ polymerization (Stewart et al., 2016).
Solid-state nuclear magnetic resonance spectroscopy has helped
to identify the interaction site of Aβ with the polysaccharide
heparin as a proxy for GAG (Madine et al., 2012). This
information is useful for further structural studies and for design
of compounds that may interfere with Aβ fibril formation.
Notably, it has been shown that the structure of Aβ fibril in AD
brains differ from that in vitro and may even be patient-specific
for different clinical variants of AD (Lu et al., 2013). More studies
into β-amyloid fibrils are therefore warranted both regarding
the neuropathology and the possibility for development of novel
treatments in AD.
Prion diseases are rare neurodegenerative disorders in
humans (such as Creutzfeldt-Jakob disease) and in animals
(Bovine Spongiform Encephalopathy) caused by the infectious
prion protein (PrP; Colby and Prusiner, 2011). Mutant and
misfolded PrP aggregates in brain tissue as amyloid fibrils
leading to spongiform changes and loss of brain cells over time.
Mounting evidence has shown that the spreading of the disease
(propagation) occurs from cell to cell during PrP replication
by misfolded PrP causing an abnormal folding of the cellular
PrP (Colby and Prusiner, 2011). The self-templating ability
of PrP is important for cell toxicity causing an exponential
increase in amyloid fibril formation that ultimately causes cell
stress and death. In PrP specific prion-like domains are present
that influence protein aggregation. Similar domains are also
found in other proteins such as in mutant TDP-43 that causes
cytoplasmic inclusions in ALS (Smethurst et al., 2016). Prion
diseases are important as models to understand the mechanisms
of protein aggregation and spreading of infectious agents in
neurodegenerative disorders. Recent studies indicate also that
a prion-like mechanism can contribute to the cell spreading of
α-synuclein in PD (Goedert et al., 2017).
In prion-infected mice, UPR and the PERK pathway was
specifically activated with a sustained increase in phospho-eIF2α
reduced the synthesis and levels of synaptic proteins causing
neuronal death (Moreno et al., 2012). In contrast, inhibition
of PERK or an overexpression of the GADD34 phosphatase
decreased the p-eIF2α level and improved synaptic functions
(Moreno et al., 2013). This lends credence to the view that
the modulation of the PERK/p-eIF2α pathway may constitute a
drug target for the development of novel therapeutics in prion
diseases.
Recent studies using gene expression profiling have revealed
changes in prion-infected mouse brain tissue including those in
specific microRNAs (Majer and Booth, 2014), and in neuronal-
specific genes that influence synaptic and brain functions (Boese
et al., 2016). These findings may help to identify important
preclinical stages and biomarkers for early diagnoses of prion
diseases.
UPR in Brain Ischemia and Epilepsy
Increased level of the excitatory amino acid glutamate is part
of the pathophysiology of brain ischemia and stroke leading to
the degeneration and loss of neurons (excitotoxic damage) in the
brain. Glutamate acts via different types of glutamate receptors
and thereby influences cell signaling cascades and elevates
intracellular calcium in neurons. Increased ER stress is linked
to brain ischemia (Su and Li, 2016) and to excitotoxic injury
as studied by the use of the glutamate receptor agonist, kainic
acid (Sokka et al., 2007; Putkonen et al., 2011). Salubrinal that
is a specific inhibitor of the eIF2α phosphatase, PP1/GADD34
(Boyce et al., 2005) and was found to protect neurons against
excitotoxicity in rat hippocampus and after cerebral ischemia
induced by 15 min of brain vessel occlusion in gerbils (Sokka
et al., 2007; Anuncibay-Soto et al., 2016).
Epilepsy is characterized by an increased electrical activity in
the brain causing repetitive seizures and neuronal dysfunctions.
The severity and recurrence of seizures vary between patients and
in most cases can be treated with drugs. In chronic temporal
lobe epilepsy in humans it was recently shown that ER stress
and particularly the IRE1α pathway are becoming activated
contributing to brain damage (Liu et al., 2013). This suggests that
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alleviation of ER stress may be beneficial in reducing neuronal
degeneration in epilepsy.
UPR and Neuropsychiatric Diseases
Studies of the role of ER stress responses in psychiatric and
mental disorders are scarce. Bipolar disorder is characterized
mood changes with alternating phases of depression and increase
activity (mania). The pathophysiology of BD is complex and
the disease is associated with other mental as well as metabolic
disorders (Kim et al., 2017). Recent data using patient-derived
blood or cell lines s showed that the ER stress response to
tunicamycin or thapsigargin is compromised in BD compared
with controls (So et al., 2007), suggesting a reduced resistance
of cells toward stress in BD. Lithium is a mood stabilizer that is
used in the treatment of BD. It was shown that lithium regulates
gene network for ER adaptation in BD cells (Breen et al., 2016).
Together this suggests that ER stress and associated pathways
may prove beneficial targets to consider in treatment of BD
(Bengesser et al., 2016) and possibly also in othermood disorders.
Regarding potential ER targets in neuropsychiatric diseases
the sigma-1 receptor localized in ER subdomains interacting
with mitochondria and is a target for several neuroactive drugs
(Hashimoto, 2015). Activation of sigma-1 receptors can afford
neuroprotection and modulates ER stress pathways in the
brain (Hyrskyluoto et al., 2013; Omi et al., 2014). The precise
roles of sigma-1 receptor and other ER resident molecules in
neuropsychiatric disease warrant further studies.
UPR AND EYE DISEASES
Photoreceptors in the retina are specialized sensory neurons for
detecting light and have a high degree of metabolic activity.
Human eye diseases affecting either the rods (responsible for
night vision) or cones (responsible for day-light and color vision)
are often caused by mutations in specific genes involved in
phototransduction or in protein quality control (Chan et al.,
2016). Achromatopsia is an eye disease with the prevalence
of about 1:30000 that affects primarily cones causing color
blindness and reduced vision in aﬄicted patients. Mutations
in cyclic-nucleotide-gated ion channel proteins, governing
phototransduction by cGMP, are common causes of congenital
forms of achromatopsia. Recently, mutations in ATF6were found
in patients with autosomal recessive achromatopsia, showing
that normal ATF6 signaling and BiP levels are crucial for
correct protein folding in the photoreceptors (Kohl et al.,
2015). The ATF6 mutations are of different types; present
either in the luminal part of ATF6 reducing its transport
or in the transcriptionally active domain interfering with its
activity (Chiang et al., 2017). Future studies will increase our
understanding about the role of ATF6 in achromatopsia and
other eye diseases.
Retinitis pigmentosa (RF) is a genetically heterogeneous
disorder that primarily affects the rods leading to blindness.
Mutations in rhodopsin is a common cause of RF and induce an
increase in UPR particularly in IRE1α/XBP1 signaling attempting
to reduce the amount of mutant rhodopsin in the ER (Chiang
et al., 2015). The increase in IRE1α activity precedes the
degeneration of the photoreceptors, however how the defects
in protein handling ultimately cause cell death is not fully
understood (Chiang et al., 2015). Like in other eye diseases,
including age-related macular degeneration, autophagy may
contribute to the pathology (Kaarniranta et al., 2013).
Cataract is a common eye disorder among elderly people
that can cause blindness. The α-crystallins, cryAA, and cryAB,
are major molecular chaperons that ensures the solubility of
lens proteins throughout life. In cataract, the crystallins are
damaged leading to misfolding and aggregation of the proteins
into insoluble amyloids impairing vision. As shown recently
small molecular compounds can stabilize and reduce aggregation
of cryAB in in vitro assays (Makley et al., 2015). These novel
substances act as pharmacological chaperons and increased lens
transparency in a heredity cataract mouse model. Furthermore,
they improved lens proteins solubility in human eye samples
indicating that they may therefore be considered as a novel
treatment for human cataracts (Makley et al., 2015). Chemical
chaperons can have beneficial actions in other protein misfolding
disorders as well, possibly in conjunction with other treatment
strategies.
UPR AND SKIN DISEASES
The prevalence of skin disorders is high and these diseases
cause much of distress for the patients. In the skin disease
vitiligo there is a selective damage of melanocytes (making the
pigment) that can occur at any age. It is though that this
can be the result of an autoimmune process or caused by
reactive oxidative species and subsequent ER stress mediated
cell degeneration (Li et al., in press). Cultured melanocytes from
vitiligo patients have enlarged ER compared with controls and
vitiligo-inducing phenol compounds activate UPR strongly in
these cells (Toosi et al., 2012) Genome-wide association studies
also support involvement of ER stress genes in vitiligo, and
genetic linkage analysis identified an association of XBP1 gene
with the development of vitiligo (Birlea et al., 2011).
Psoriasis is the most common chronic inflammatory skin
disease. Recently, variations in the autophagy related 16 like-
1 gene were found associated with psoriasis vulgaris and
palmoplantar pustulosis (Douroudis et al., 2012). The roles of
UPR signaling and ER stress in the pathogenesis of psoriasis
warrant further studies.
UPR IN METABOLIC AND INFLAMMATORY
DISEASES
Many chronic human diseases are characterized by metabolic
changes and activation of cell stress signaling that contribute
to pathology (Hotamisligil and Davis, 2016). The interactions
between metabolism and stress pathways are manifold and
involve nutritional signals and hormones such as insulin and
controlling anabolic and catabolic pathways. Inflammation
is a major component in metabolic diseases and these are
consequently named metaflammation disorders (Hotamisligil
and Erbay, 2008). Deregulated metabolism may also influence
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the immune system, and high cholesterol was shown to impair
immune cells causing autoimmune diseases (Ito et al., 2016).
Increased cell stress and UPR are also frequent in type 2 diabetes,
in lipid disorders, in obesity, and in cardiovascular diseases
(Hotamisligil and Davis, 2016).
Signaling via Toll-like receptor-2 (TLR2) and TLR4 in
macrophages can activate IRE1 and induced XBP1 splicing
increasing the production of proinflammatory cytokines
contributing the inflammation (Martinon et al., 2010). The
IRE1α/XBP1 pathway is activated as shown in cells obtained
from synovial fluids of patients with rhemathoid arthritis (Qiu
et al., 2013). Treatment with the compound 4µ8C inhibited
IRE1α, reduced pro-inflammatory cytokine production and
alleviated the joint inflammation in mice with experimental
arthritis (Qiu et al., 2013).
Diabetes and β-Cells
Mounting evidence has shown a link between UPR and the
development of diabetes with an altered insulin secretion,
reduced β-cell viability and increased insulin resistance (IR) in
peripheral tissues (Cardozo and Cnop, 2008; Salvadó et al., 2015).
Lipotoxicity is a key trigger for β-cell dysfunction and saturated
fatty acids are known to induce the PERK and IRE1α pathways
(Sommerweiss et al., 2013). Increased insulin synthesis during IR
leads to accumulation of misfolded insulin that further activates
the UPR (Han et al., 2013). UPR causes accumulation of the
human islet amyloid polypeptide, which occurs in 90% of T2D
patients (Cadavez et al., 2014). Chaperons ameliorating the ER
stress response can increase insulin secretion, pointing to novel
therapeutic possibilities in β-cell rescue (Cadavez et al., 2014).
The IRE1α/XBP1 branch of UPR plays a critical role in regulation
of glucose and lipid metabolism in various diseases (Sha et al.,
2011; Jiang et al., 2015). Activated JNK cascade contribute to
obesity and insulin resistance by phosphorylation of the insulin
receptor substrate, IRS-1 that attenuates insulin signaling (Ozcan
et al., 2004).
Atherosclerosis and Heart Diseases
In atherosclerosis, macrophages infiltrate the vessel wall and
accumulate lipids and lipotoxic substances that sustain the local
inflammation. In addition saturated fatty acids such as palmitate
can active the IRE1α/XBP1 axis in these cells. The use of the
chemical chaperone 4-phenyl butyric acid (4-PBA) was found
to mitigate ER stress and reduce the amount of atherosclerotic
lesions in vivo (Erbay et al., 2009). 4-PBA acts by decreasing
the level of the fatty acid-binding protein-4 (aP2) that is crucial
for inducing lipotoxic stress in macrophages. Lipid chaperones,
acting as fatty acid sensors in these cells, may provide novel
targets to consider for treating dyslipidemias (Erbay et al., 2009).
In addition, the bioactive lipid palmitoleate also protected against
macrophage ER stress and prevented atherosclerosis (Çimen
et al., 2016). It remains to be studied whether supplementation
with PAO can be of value in treatments of lipid and other
metabolic disorders in humans. Recently, the use of the specific
IRE1α inhibitor, STF-083010 in mice was shown to reduce
atherosclerotic plaque size, lipid-induced inflammation and
cytokine production in vivo (Tufanli et al., 2017), suggesting that
alleviation of ER stress may provide therapeutic benefits also in
cardiovascular diseases.
ER stress is also involved in hearth diseases such as myocardial
ishemic/infarction and cardiomyopathies. Historically it was
shown that heart failure is characterized by morphological
changes in the ER, as a hallmark for the ER overload and ongoing
stress (Maron et al., 1975). In cellular models, pressure overload
induces ER stress and apoptosis in cardiacmyocytes (Okada et al.,
2004). These finding were confirmed in preclinical experiments
with mice. Increased GRP78 expression has been shown in
patients with heart failure (Minamino et al., 2010). Myocardial
infarction also induces ER stress involving increased oxidative
stress reactions. Recent data show a role for the ATF6 pathway
in counteracting oxidative stress and counteracting ischemia and
reperfusion injury in cardiomyocytes and in mouse hearts in
vivo (Jin et al., 2017). Activation of XBP1 contributes to tissue
adaptation and hypertrophy following heart injury by regulating
the expression of the pro-angiogenic factor, vascular endothelial
growth factor-A (VEGF-A) in vivo (Duan et al., 2016). The
regulation of VEGF-A by the IRE1α/XBP1 pathway is probably of
general significance in other ischemic disorders as well. Recently,
it was reported that sirtuin-1 (SIRT1) counteracts ER stress
and reduces the PERK/eIF2α pathway in the injured heart via
deacetylation of eIF2α (Prola et al., 2017). This opens up a novel
pathway for cardioprotection and for mitigation of ER stress via
SIRT1 that itself can be activated by chemical compounds.
In the clinics the use of anticancer drugs can also impinge on
the heart to cause dysfunctions in protein quality control events.
Cardiotoxicity of such drugs are often linked to the induction
of ER stress but also to changes in autophagy and the ubiquitin
proteasome system; for a detailed discussion on this see the recent
review (Fu et al., 2017).
Liver Metabolism and ER Stress
Liver is the central organ in the regulation of metabolism and
it ties together different metabolic challenges (lipids, toxins)
with the responses in other organs. In many metabolic diseases
ER stress and UPR are activated in hepatocytes that eventually
can lead to liver damage. UPR in hepatocytes is important to
balance fluctuations in blood glucose levels and under diabetic
conditions sustained UPR leads to ER stress in the liver (Ji and
Kaplowitz, 2006). ER stress itself can induce enzymes involved in
gluconeogenesis modulating glucose cycling in the liver (Wang
et al., 2006). Altered metabolism in form of diets containing
high-carb and high saturated fats can induced accumulation of
lipids (steatosis) in the liver characterized by increased ER stress
(Sozen and Ozer, 2017). The induction of ER stress and steatosis
precedes obesity and changes in insulin action and a sustained ER
stress can worsen the metabolic dysregulation through activation
of lipidogenic genes. Over-expression of ER chaperone, ORP150
was found to improve insulin resistance and ameliorate glucose
tolerance in diabetic animals (Ji and Kaplowitz, 2006). Steatosis
and chronic inflammation are also characteristics of alcoholic
liver injury. Activation of signaling molecule such as p38 MAPK
by inflammatory cytokines can further aggravate lipotoxicity and
ER stress and lead to ER/Golgi remodeling (Koeberle et al., 2015).
Activation of SREBP signaling by ER stress is responsible for the
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 May 2017 | Volume 5 | Article 48
Lindholm et al. UPR and ER Stress in Human Diseases
accumulation of lipids also in alcoholic liver models (Esfandiari
et al., 2005). Targeting and relieving ER stress can reverse liver
damage and protect also other tissues from harmful effects.
UPR IN LUNG DISEASES
ER stress has been shown to play a role in acute lung injuries, in
sepsis (Khan et al., 2017), as well in more chronic lung disorders.
Increased inflammation accompany lung injuries and treatment
with the inhibitor 4-PBA alleviated ER stress and decreased levels
of inflammatory cytokines in a mouse model of lung injury
and in lung alveolar epithelial cells (Zeng et al., 2017). Lung
endothelial cells are also vulnerable to ER stress induced among
others by high fat diet causing endothelial cell dysfunctions that
were reversed by 4-PBA (Shah et al., 2017). Sepsis is a severe
conditionwith increased ER stress and acute organ failure leading
to reduced respiration.
Chronic lung diseases are characterized by increased fibrosis
resulting in reduced gas exchange and tissue oxygenation.
Chemicals irritations, particle exposition and smoking contribute
to the chronic inflammation observed in the lung including a
sustained UPR response (Zhang et al., 2017). This in turn leads
to the activation of fibroblast, with cellular remodeling and an
increased formation of collagen and related molecules in the lung
(Lawson et al., 2011). Inflammatory cytokines and growth factors
such as transforming growth factor-beta contribute to tissue
fibrosis. In the human lung disease, idiopathic pulmonary fibrosis
the UPR is activated suggesting novel therapeutic targets (Zhang
et al., 2017). Currently novel drug treatments of idiopathic
pulmonary fibrosis have been introduced that show therapeutic
benefits in the disease (Myllärniemi and Kaarteenaho, 2015;
Rochwerg et al., 2016). It remains to be shown whether targeting
the UPR pathways may have additional value in the treatments of
this or other lung diseases.
Modulation of UPR signaling pathways by different drugs and
chemicals has also been used to successfully induce cell death of
human lung cancer cells (Zhang et al., 2016; Yang et al., 2017).
UPR IN KIDNEY DISORDERS
In chronic kidney diseases, hypoxia, tissue inflammation,
increased oxidative, and ER stress are prevalent findings that
together affect the glomeruli and compromise the normal
function of the kidney (Maekawa and Inagi, 2017). In particular,
podocytes are vulnerable cells and the injury or dysfunctions of
these cells can lead to progressive defects in the globular filtration
barriers, with proteinuria, and kidney failure as consequences
(Maekawa and Inagi, 2017).
Diabetic nephropatia (DN) is characterized by hyperglycemia,
increased proteinuria and UPR activation causing podocyte
malfunctions and increased cell stress, with advanced glycation
end products and free fatty acids present in the kidney (Zhuang
and Forbes, 2014). Chronic DN is a major cause of organ
failure and death in diabetes calling for preventive measures and
treatments. It has recently been shown that tauroursdeoxycholic
acid, inhibiting ER stress, counteracted podocyte and glomeruli
injury, reduced proteinuria and improved kidney functions in
a diabetic mouse model (Fan et al., 2017). In addition, the ER
associated protein, reticulon (RTN1A) was identified a critical
factor in induction of ER stress in kidney tubular cells (Fan et al.,
2017). High expression of RTN1A has also been linked to human
DN and other kidney diseases, suggesting a novel target for future
alleviations of ER stress in kidney diseases (Fan et al., 2015).
UPR IN AGING AND TRANS-CELLULAR
COMMUNICATION
Caloric restriction and altered metabolic signaling including
insulin/insulin-like growth factor, and mTOR pathways have
been linked to longevity in different organisms (Henis-Korenblit
et al., 2010; Guarente, 2011). In C. elegans the XBP1 pathway
regulates resistance to ER stress and lifespan in conjunction
with the DAF-16/FOXO signaling (Ben-Zvi et al., 2009). The
capacity to mount an UPR response decreases with age (Ben-
Zvi et al., 2009). Recent studies have further shown that neuronal
overexpression of an active XBP1 increases restores proteostasis
not only in neurons but also in distal non-neuronal tissues
(Taylor and Dillin, 2013). This trans-cellular communication
of UPR signaling requires neuronal activity and may help to
coordinate longevity between different tissues in C. elegans
(Taylor and Dillin, 2013). However, the underlying mechanisms
and whether similar processes exist in other organisms remain to
be established.
Studies of aging and protein quality control in the yeast,
Saccharomyces cerevisiae have shown that that damaged and
aggregates proteins are segregated between mother and daughter
cells so that potentially harmful proteins are eliminated from
the progeny. Vacuole fusion in the yeast is important for
this process that is controlled by asymmetry-generating genes
including the myosin-dependent adaptor protein Vac17 (Hill
et al., 2016). Overexpression of Vac17 also reduced the amount
of misfolded protein aggregates and prolonged life span in
yeast. The tight links shown between the age-dependent
increased in protein aggregation and reduced endosome
trafficking may have relevance for the aging process in other
cells as well. Furthermore, antioxidant enzymes such as the
Peroxiredoxins (Prxs), scavenging hydrogen peroxides, modulate
aging associated with metabolic signaling. In yeast the anti-
aging effect of the antioxidant Tsai involves hyperoxidation of
the molecule facilitating the binding of chaperons including the
heath shock protein, Hsp70 to misfolded proteins (Hanzén et al.,
2016). Prxs and Hsp70 are both elevated in cancer cells and it
would be important to know whether a similar mechanism for
chaperon regulation occurs in human tumors and other cells.
UPR AND ER STRESS IN CANCER
Rapidly growing tumor cells face different types of environmental
stressors in form of hypoxia, glucose deprivation, inadequate
vascularization, and metabolic challenges. In addition to
the external stressors, internal activation of oncogenes,
accumulation of somatic mutations, genome instability, changes
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in chromosome number lead to the additional demands for ER
pathways. Tumor cells also adapt to the relative lack of glucose
by an increased rate of aerobic glycolysis known as the Warburg
effect. To overcome restrains for growth, cancer cells mount
an increase in UPR to cope with cell stress and to counteract
cell death (Vandewynckel et al., 2013; Kim et al., 2015). Many
studies have found sustained and high-level activation of the
ER stress genes in variety of solid tumors (Fernandez et al.,
2000; Shuda et al., 2003; Moenner et al., 2007). The IRE1α/XBP1
pathway is largely activated in different types of cancer including
breast cancer, multiple myeloma, colorectal cancer, and gliomas
(Chen X. et al., 2014). IRE1α activation is tumor cells is linked
to an increased ER protein folding capacity, ERAD activity,
enhanced production of angiogenic factors (VEGF) and restored
protein homeostasis. Expression of chaperones renders cancer
cells resistant to the pro-apoptotic signals and this correlates
to the degree of malignancy of the tumor. The ER chaperones
GRP78/BiP andGRP94/HSP90B1 are increased inmany different
cancers (Moenner et al., 2007). GRP78/BiP plays a role in cancer
also by localizing to the cell surface after being released (Tsai
et al., 2015). GRP78/BiP can interact with membrane proteins or
those in the tumor microenvironment influencing cell signaling
cascades, cell proliferation, and immune reactions important for
the cancer cell survival (Vandewynckel et al., 2013). In addition,
the chaperon GRP170/ HYOU1 has been found to be specifically
overexpressed in human breast and thyroid cancers (Kretowski
et al., 2013; Zong et al., 2016). Increased PERK activation
has also been linked to growth and progression/metastasis of
tumors such as colorectal cancer, esophageal, and breast cancer
and this can partly be explained by reduced DNA damage an
increased angiogenesis (Bobrovnikova-Marjon et al., 2010;
Vandewynckel et al., 2013). PERK can also affect the cell cycle
and act in a tumor-suppressive manner inducing cell dormancy
(Vandewynckel et al., 2013). In view of this and other observation
it is not always clear whether sustained ER stress in cancer cells
promotes or inhibits tumor growth as this can vary between the
different stages of tumor formation (Vandewynckel et al., 2013;
Kim et al., 2015).
Therapeutic Possibilities in Cancer
As ER stress has obvious role in the survival of cancer cells,
IRE1α, and PERK are attractive candidates for drug development
(Maly and Papa, 2014; Jiang et al., 2015). Several small molecules
have been identified, that are able to inhibit IRE1α. These
compounds are shown to have some anti-myeloma activity,
but there are serious concerns about the selectivity of these
compounds. Mores specific inhibitors, IRE1α kinase inhibiting
RNase attenuators (KIRAs) that inhibit IRE1α RNAse, have been
developed (Wang et al., 2012). KIRAs are able to inhibit XBP1
RNA cleavage, mRNA decay in ER and IRE1α activity and they
TABLE 1 | Compounds targeting ER stress signaling and used in different experimental settings.
Disorder Chemical
compound
UPR branch/target Effects References
ALS Sephin1 Inhibition of stress-induced
phosphatase
p-eIF2α is increased
Neuroprotection Das et al., 2015
Excitotoxicity Brain ischemia Salubrinal Inhibits GADD34
p-eIF2α increased
Neuroprotection Sokka et al., 2007;
Anuncibay-Soto et al., 2016
PD Salubrinal p-eIF2α increased Neuroprotection in α.synuclein mouse
model
Colla et al., 2012
Drug abuse ISRIB Increase in the eIF2B guanine
nucletide exchange factor
Increase p-eIF2α translation and
Induction of LTP by cocaine
Placzek et al., 2016
Prion disease GSK2606414 PERK inhibitor
p-eIF2α reduced
Increase in synaptic proteins
and reduced neurodegeneration
Moreno et al., 2013
Inflammation arthritis 4µ8C IRE1 pathway/ inhibits XBP-1 splicing reduced cytokines
improvement of model of rheumatoid
arthritis
Qiu et al., 2013
Multiple myelom MKC-3946 inhibits XBP-1
splicing
Growth inhibition Mimura et al., 2012
Pancreatic cancer cell STF-083010 IRE1 inhibition Growth retardation
Tumor cells Irestin IRE1-RNase inhibitor, blocks XBP1
effects
Tumor cell survival reduced
Hepatocellular carcinoma GSK2656157 or
4µ8C +oprozomib
PERK inhibitor
IRE inhibitor
Proteasome inhibitor
Antitumor effects Vandewynckel et al., 2016
Cultured cells Compound 147 ATF6
activators
Reduced secretion of misfolded
protein protein
Plate et al., 2016b
Osteosarcoma cells Ceapins ATF6 inhibitor Sensitizes cells to ER stress Gallagher et al., 2016
Summary of small molecules and compounds used to experimentally address ER stress pathways in different disorders. The list gives a glimpse into reported activities in this rapidly
progressing field. For more details please see the main text.
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FIGURE 2 | Schematic view of the role of UPR in cell homeostasis and
disease. UPR is an adaptive pathway in the ER that promotes homeostasis
and increases proteostasis (correct folding and secretion of proteins) in the
cell. UPR signaling occurs by activation of three transmembrane sensor
proteins in the ER (above right) by mechanisms that are described more in the
text. Prolonged or heavily sustained UPR can lead to ER stress that can results
in full-blow disease. Some of the mechanisms mediating cell degeneration are
shown here including the ASK/JNK and CHOP cell death signaling that in
many cases involves activation of caspases. Alterations in calcium handling
and oxidative stress occurring in ER stress are not depicted here. UPR and ER
stress act in concert with other cell stress pathways involving mitochondria
and autophagy. Recent studies have identified small molecular compounds
that target the UPR signaling pathways, having beneficial actions in various
disease models as discussed in the text. In view of the delicate balance
between different pathways in homeostasis it is important to know what would
be the best timing for drug treatments to alleviate ER stress (see arrows). In
addition, chemical chaperons and other therapies are also potentially useful as
drugs in different diseases. Increased knowledge about the role of UPR and
ER stress and cellular interactions during cell stress can in the long-run lead to
novel treatment strategies in various human disorders.
are shown to protect against ER stress induced damages (Ghosh
et al., 2014).
Potent and selective inhibitors of PERK’s kinase domain have
also been developed, and one such compound, GSK2656157
revealed promising anti-tumor effects in preclinical models
of pancreatic adenocarcinoma and multiple myeloma (Atkins
et al., 2013). Main issue with all these inhibitors are their side
effects as for examples PERK inhibitors cause pancreatic β-
cell loss and diabetes (Oakes, 2017). Therefore, while ER stress
is necessary for the cancer progression and spread, the utility
of ER stress inhibitors as anti-cancer drugs in the clinics will
require careful consideration and critical evaluation of benefits
and drawbacks. One possibility for treatment would be to
combine UPR inhibitors with those targeting the proteasome as
shown recently in case of models of hepatocellular carcinoma
(Vandewynckel et al., 2016).
CONCLUSIONS AND FUTURE
PROSPECTS
UPR as part of the cell protein quality control system is
an important process to optimize cell functions and correct
aberrations caused by cell stress. Recent developments in the field
have shown that UPR plays a role not only in different diseases
but also in physiological processes including the regulation of
cell metabolism, inflammation, aging and neuronal plasticity,
and cognition. Figure 1 shows some human diseases in which
activated UPR/ER stress is thought to play a part. Progress in
this field has been facilitated by the development of chemical
compounds and inhibitors targeting the UPR signaling pathways
with a high degree of specificity (Das et al., 2015; Gallagher et al.,
2016; Plate et al., 2016b). Table 1 summarizes small molecules
that have been used to target different branches of ER stress
in various disorders. The list is only tentative to give a short
glimpse into the current state of development and keeping in
mind that several experiments are on-going and as such not
yet reported. As evident from several studies the timing in the
use and the concentration of each compound are important
aspects to consider when targeting the different pathways in
disease (Figure 2). Mounting evidence also indicates that UPR
signaling and ER stress are intimately linked to other cellular
pathways such as autophagy and proteasomes involved in protein
degradation. In addition, although UPR is associated with ER
functions the interactions with organelles such as mitochondria
and the UPR(mt) response is important for the final outcome
in cell stress. In the future, it will be important to study these
interactions further to reveal the precise functions of each
signaling pathway and molecules in the cell stress responses
in different human pathologies. Given the current pace of
research it is foreseen that new discoveries will emerge regarding
both the regulatory mechanisms and the possibilities for better
treatments of various diseases involving UPR activation and ER
stress.
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